CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan

Clinical trial NCT00562419 · UNKNOWN

Trial details

NCT number: NCT00562419
Sponsor: Adnexus, A Bristol-Myers Squibb R&D Company
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Recurrent Glioblastoma Multiforme

Start date: 2007-10-01
Primary completion: 2011-06-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.